Biocon Ltd Financials

Biocon Ltd Financial Statement

Biocon Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	598.90	552.50	571.50
Operating Expense	487.80	465.70	480.40
Net Profit	3.20	0.90	14
Net Profit Margin	0.53	0.16	2.45
Earning Per Share	0.03	0.01	0.12
EBIDTA	106.60	89	74
Effective Tax Rate	11.88	2.76	-10.21

Particulars	Sep 2024
Revenue	598.90
Operating Expense	487.80
Net Profit	3.20
Net Profit Margin	0.53
Earning Per Share	0.03
EBIDTA	106.60
Effective Tax Rate	11.88

Biocon Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	2,127.30	1,992.90	1,738.20
Operating Expenses Annual	1,864.60	1,969.40	1,677.10
Operating Profit Annual	470.20	3,157.70	248.30
Interest Annual	198.80	69.60	0.40
Depreciation	114.10	108.30	100.70
Net Profit Annual	119.30	2,848.40	86.10
Tax Annual	31	122.80	53.60

Particulars	Mar 2024
Total Revenue Annual	2,127.30
Operating Expenses Annual	1,864.60
Operating Profit Annual	470.20
Interest Annual	198.80
Depreciation	114.10
Net Profit Annual	119.30
Tax Annual	31

Biocon Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	196.60	111	253.50
Cash Flow from Operations	-123.20	219.30	47.60
Cash Flow from Investing	-294.70	-1,173.10	-302.10
Cash Flow from Financing	343.60	1,039.40	112
Cash Flow at the End	122.30	196.60	111

Particulars	Mar 2024
Cash Flow at the Beginning	196.60
Cash Flow from Operations	-123.20
Cash Flow from Investing	-294.70
Cash Flow from Financing	343.60
Cash Flow at the End	122.30

Biocon Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	21.31	13.60	14.28
PBIT Margin (%)	15.62	7.74	8.06
PBT Margin (%)	15.54	7.63	-12.09
Net PROFIT Margin (%)	5.61	142.93	4.95
Return On Networth / Equity (%)	0.97	-0.14	1.08
Return On Networth /Employed (%)	2.61	1.50	1.72
Return On Assets (%)	0.95	27.16	1.04
Total Debt / Equity (X)	0.15	0.07	0.01
Asset Turnover Ratio (%)	0.17	0.19	0.21

Particulars	Mar 2024
PBDIT Margin (%)	21.31
PBIT Margin (%)	15.62
PBT Margin (%)	15.54
Net PROFIT Margin (%)	5.61
Return On Networth / Equity (%)	0.97
Return On Networth /Employed (%)	2.61
Return On Assets (%)	0.95
Total Debt / Equity (X)	0.15
Asset Turnover Ratio (%)	0.17

Biocon Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	915	914	819.30
Total Current Assets Annual	2,760	2,566	2,402.20
Non Current Assets Annual	11,008.20	10,463.90	6,466.80
Total Shareholders Funds Annual	10,912.30	10,916	8,092.90
Total Assets Annual	13,768.20	13,029.90	8,869

Particulars	Mar 2024
Fixed Assets Annual	915
Total Current Assets Annual	2,760
Non Current Assets Annual	11,008.20
Total Shareholders Funds Annual	10,912.30
Total Assets Annual	13,768.20

Biocon Ltd Earning Calls

EPS (INR)

Expected

0.00

Reported

-0.13

Surprise

0.00%

Jun 2024

EPS beaten by 0.00%

Mar 2024

EPS beaten by 0.36%

Dec 2023

EPS beaten by 0.00%

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 25, 2024, Biocon Ltd has a market capitalization of 31,707.85 Cr. Value Research classifies it as a Large-Cap company.

Yes, Biocon Ltd is debt-free with a debt-to-equity ratio of 0.19.

In FY 2023 , Biocon Ltd recorded a total revenue of approximately 2,127.30 Cr marking a significant milestone in the company's financial performance.

Biocon Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and 0.1% annually, respectively..

Biocon Ltd's current PE ratio is 265.78.

Biocon Ltd's ROCE averaged 1.9% from the FY ending March 2022 to 2024, with a median of 1.7%. It peaked at 2.7% in March 2024, reflecting strong capital efficiency over the period..

Biocon Ltd's latest EBIT is Rs. 349.10 Cr, surpassing the average EBIT of Rs. 1,176.67 Cr over the 5 years..